Back

Effects of the Atrial fibrillation Better Care (ABC) pathway on outcomes among clinically complex chinese patients with atrial fibrillation with multimorbidity and polypharmacy.

3 April 2022 (00:00 - 00:00)
Organised by:
Congress Presentation Part of: ePosters Day 2 Clinical EHRA Premium Access EHRA 2022

About the speaker

Photo
Doctor Maria Stefil

Royal Adelaide Hospital, Adelaide (Australia)

131 More presentations in this session

Presentation thumbnail
Folates dysmetabolism promotes atrial cardiomyopathy/fibrillation through a cardiac-bone marrow networking involving endothelial progenitor cell dysfunction and erythropoiesis diversion
Doctor L. Sgarra (Acquaviva Delle Fonti, IT)
Abstract Slides
Presentation thumbnail
Pure and impure tachycardiomiopathy: key differences and long term prognosis
Doctor G. Stronati (Ancona, IT)
Abstract Slides
Presentation thumbnail
Prognostic value of plasma neutrophil gelatinase-associated lipocalin for cardiovascular events in patients with chronic heart failure and atrial fibrillation
Professor D. Lashkul (Zaporizhzhya, UA)
Abstract Slides
Presentation thumbnail
Interatrial block as a prognosticator of new-onset atrial fibrillation: prospective observational study of 8012 adults
Mr E. Abdovic (Zenica, BA)
Abstract Slides
Presentation thumbnail
CHA2DS2-VASc score and the risk of death in atrial fibrillation
Doctor A. Aro (Helsinki, FI)
Abstract Slides

Access the full session

Session thumbnail
ePosters Day 2

The Event

Event poster

EHRA 2022

3 April - 5 April 2022
You may be interested in
thumbnail
Congress Presentation
Interactive discussion and Q&A
thumbnail
Congress Presentation
Device-detected or clinically diagnosed atrial fibrillation: the same decision for oral anticoagulation therapy - discussion
thumbnail
Congress Presentation
Oral anticoagulation in subclinical atrial fibrillation: pro

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources